Clinical trial
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage…
NCT00003691 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003691 |
|---|---|
| Title | Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer |
| Official title | A Randomized Study of Doxorubicin Plus Cisplatin Versus Doxorubicin Plus Cisplatin Plus 3-Hour Paclitaxel With G-CSF Support in Patients With Primary Stage III & IV or Recurrent Endometrial Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cisplatin, doxorubicin hydrochloride, paclitaxel |
| Enrollment | 240 |
| Start date | Dec 1, 1998 |
| Primary completion | Jun 1, 2004 |
| First posted | Jun 24, 2004 |
| Last update posted | Jul 9, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: